Evidence map›Paper›PMID 41033690›Full record

ArticleBMJ global health2025

Global, regional and national burden of chikungunya: force of infection mapping and spatial modelling study.

Hyolim Kang, Ahyoung Lim, Megan Auzenbergs, Andrew Clark, Felipe J Colón-González, Henrik Salje, Hannah Clapham, Jean Paul Carrera, Jong-Hoon Kim, Maya Malarski and 7 more

Abstract read
In one paragraph

Article in BMJ global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. New article types atBMJ global health · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Hyolim KangLondon School of Hygiene and Tropical Medicine, London, UK hyolim.kang@lshtm.ac.uk.ORCID 0000-0002-0123-6387
Ahyoung LimLondon School of Hygiene and Tropical Medicine, London, UK.
Megan AuzenbergsLondon School of Hygiene and Tropical Medicine, London, UK.
Andrew ClarkLondon School of Hygiene and Tropical Medicine, London, UK.
Felipe J Colón-GonzálezData for Science and Health, Wellcome Trust, London, UK.
Henrik SaljeDepartment of Genetics, University of Cambridge, Cambridge, UK.
Hannah ClaphamSaw Swee Hock School of Public Health, National University of Singapore, Singapore.ORCID 0000-0002-2531-161X
Jean Paul CarreraGorgas Memorial Institute for Health Studies, Panama City, Panama.
Jong-Hoon KimInternational Vaccine Institute, Seoul, South Korea.ORCID 0000-0002-9717-4044
Maya MalarskiGavi, the Vaccine Alliance, Geneva, Switzerland.
Sandra López-VergèsGorgas Memorial Institute for Health Studies, Panama City, Panama.
Zulma M CucunubáPontificia Universidad Javeriana, Bogota, Colombia.ORCID 0000-0002-8165-3198
Thiago Cerqueira-SilvaLondon School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0003-4534-2509
William John EdmundsLondon School of Hygiene and Tropical Medicine, London, UK.
Sushant SahastrabuddheInstitute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
Oliver J BradyLondon School of Hygiene and Tropical Medicine, London, UK.
Kaja AbbasLondon School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0003-0563-1576

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionChikungunya virus, an arbovirus transmitted by

methodsWe used a random forest model to predict force of infection and estimate chikungunya burden at high spatial resolution (5×5 km) using covariates from climatic, socioeconomic and ecological domains. We used a focal scenario to estimate the observed burden (lower bound) and an at-risk scenario to estimate the potential burden (upper bound) of chikungunya transmission.

resultsWe predicted global long-term average annual force of infection at 0.012 (95% UI: 0.007 to 0.019) for focal scenario and 0.013 (95% UI: 0.005 to 0.03) for at-risk scenario in 103 countries. We estimated global chikungunya burden annually of 14.4 million (95% UI: 11.0 to 17.8 million) infections and 0.96 million (95% UI: 0.56 to 1.6 million) disability-adjusted life years (DALYs) in the focal scenario, and 34.9 million infections (95% UI: 26.7 to 43.1 million) and 2.3 million DALYs (95% UI: 1.4 to 3.8 million) in the at-risk scenario for 2020. The chronic phase accounts for 54% of chikungunya burden, with relatively higher burden among 40-60-year-old population, with mortality disproportionately affecting children under 10 and adults over 80.

conclusionWhile chikungunya transmission has high geographical uncertainty, high force of infection is not limited to tropical regions and is distributed across all continents. Our estimates of chikungunya burden are useful for prioritisation of regions and target age groups for chikungunya vaccine introduction.

Indexed as

Chikungunya FeverCost of IllnessGlobal HealthAdultAedesChikungunya virusChildHumansMiddle AgedSpatial AnalysisArbovirusesEpidemiologyGlobal HealthMathematical modelling

Identifiers

PMID41033690
PMCPMC12506043

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.